Mirae Asset Global Investments’s Cellectis CLLS Stock Holding History

Mirae Asset Global Investments’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-210,659	Closed	-$482K	–	2540
2022 Q3	$482K	Buy	210,659 +24,641	+13%	+$74.7K	﹤0.01%	1886
2022 Q2	$526K	Buy	186,018 +43,677	+31%	+$154K	﹤0.01%	1724
2022 Q1	$646K	Sell	142,341 -26,678	-16%	-$147K	﹤0.01%	1412
2021 Q4	$1.37M	Buy	169,019 +45,762	+37%	+$450K	﹤0.01%	1207
2021 Q3	$1.55M	Buy	123,257 +23,048	+23%	+$319K	﹤0.01%	1181
2021 Q2	$1.55M	Buy	100,209 +5,512	+6%	+$92.7K	﹤0.01%	1130
2021 Q1	$1.91M	Buy	94,697 +43,218	+84%	+$1.07M	0.01%	965
2020 Q4	$1.39M	Buy	+51,479	New	+$1.15M	0.01%	1044

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Mirae Asset Global Investments's CLLS Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 210,659 shares — an estimated $482K sold.

Mirae Asset Global Investments first reported a position in CLLS in Q4 2020 and held it in 8 quarters. The position peaked at $1.91M in Q1 2021. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

Mirae Asset Global Investments reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
Mirae Asset Global Investments sold 210,659 Cellectis shares in Q4 2022, an estimated $482K.
Mirae Asset Global Investments first reported a position in Cellectis in Q4 2020 and held it in 8 quarters.
Mirae Asset Global Investments's Cellectis position peaked at $1.91M in Q1 2021.
40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.